Literature DB >> 16485124

Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease.

Fabian Schnitzler1, Stephan Brand, Tanja Staudinger, Simone Pfennig, Katrin Hofbauer, Julia Seiderer, Cornelia Tillack, Burkhard Göke, Thomas Ochsenkühn, Peter Lohse.   

Abstract

We performed a limited DNA sequence analysis of the CARD15 gene in 89 patients with Crohn's disease (CD), 19 patients with ulcerative colitis (UC), and three patients with indeterminate colitis (IC), who were heterozygous carriers of one of the common CARD15 mutations [c.2104C>T (p.R702W), c.2722G>C (p.G908R), or c.3019_3020insC (p.Leu1007fsX1008)], the c.2462+10A>C variant, or of a new amino acid substitution in the 3'-end of exon 4. CARD15 exons 4, 5, 6, 8, and 11 were amplified by PCR and completely sequenced, thereby theoretically covering 73.9% of the described CARD15 variants and 96.6% of the mutated alleles. Using this approach, eight novel amino acid substitutions [c.1171C>T (p.R391C), c.1387C>G (p.P463A), c.2138G>A (p.R713H), c.2278C>T (p.R760C), c.2368C>T (p.R790W), c.2371C>T (p.R791W), c.2475C>G (p.N825K), and c.2546C>T (p.A849V)] were detected in six CD and two IC patients, and one UC patient. A severe disease phenotype was observed especially in patients who are compound-heterozygous for a common and a novel CARD15 mutation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16485124     DOI: 10.1007/s00251-005-0073-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  21 in total

1.  Mutational analysis of the Arabidopsis nucleotide binding site-leucine-rich repeat resistance gene RPS2.

Authors:  Y Tao; F Yuan; R T Leister; F M Ausubel; F Katagiri
Journal:  Plant Cell       Date:  2000-12       Impact factor: 11.277

2.  Significant role of genetics in IBD: the NOD2 gene.

Authors:  Judy H Cho
Journal:  Rev Gastroenterol Disord       Date:  2003

3.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

4.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

6.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

Review 7.  Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.

Authors:  Mathias Chamaillard; Stephen E Girardin; Jérôme Viala; Dana J Philpott
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Authors:  Maria T Abreu; Kent D Taylor; Ying-Chao Lin; Tieu Hang; Joanne Gaiennie; Carol J Landers; Eric A Vasiliauskas; Lori Y Kam; Micha Rojany; Konstantinos A Papadakis; Jerome I Rotter; Stephan R Targan; Huiying Yang
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  19 in total

1.  The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.

Authors:  Matthias Jürgens; Stephan Brand; Rüdiger P Laubender; Julia Seiderer; Jürgen Glas; Martin Wetzke; Johanna Wagner; Simone Pfennig; Cornelia Tillack; Florian Beigel; Maria Weidinger; Fabian Schnitzler; Martin E Kreis; Burkhard Göke; Peter Lohse; Karin Herrmann; Thomas Ochsenkühn
Journal:  J Gastroenterol       Date:  2010-04-29       Impact factor: 7.527

2.  Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset.

Authors:  Jürgen Glas; Julia Seiderer; Melinda Nagy; Christoph Fries; Florian Beigel; Maria Weidinger; Simone Pfennig; Wolfram Klein; Jörg T Epplen; Peter Lohse; Matthias Folwaczny; Burkhard Göke; Thomas Ochsenkühn; Julia Diegelmann; Bertram Müller-Myhsok; Darina Roeske; Stephan Brand
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

3.  The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.

Authors:  Martin Storr; Dominik Emmerdinger; Julia Diegelmann; Simone Pfennig; Thomas Ochsenkühn; Burkhard Göke; Peter Lohse; Stephan Brand
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

4.  Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.

Authors:  Martin A Storr; Catherine M Keenan; Dominik Emmerdinger; Hong Zhang; Birol Yüce; Andrei Sibaev; Federico Massa; Nancy E Buckley; Beat Lutz; Burkhard Göke; Stephan Brand; Kamala D Patel; Keith A Sharkey
Journal:  J Mol Med (Berl)       Date:  2008-05-21       Impact factor: 4.599

5.  CEACAM6 gene variants in inflammatory bowel disease.

Authors:  Jürgen Glas; Julia Seiderer; Christoph Fries; Cornelia Tillack; Simone Pfennig; Maria Weidinger; Florian Beigel; Torsten Olszak; Ulrich Lass; Burkhard Göke; Thomas Ochsenkühn; Christiane Wolf; Peter Lohse; Bertram Müller-Myhsok; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.

Authors:  Jürgen Glas; Julia Seiderer; Cornelia Tillack; Simone Pfennig; Florian Beigel; Matthias Jürgens; Torsten Olszak; Rüdiger P Laubender; Maria Weidinger; Bertram Müller-Myhsok; Burkhard Göke; Thomas Ochsenkühn; Peter Lohse; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

7.  PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.

Authors:  Jürgen Glas; Johanna Wagner; Julia Seiderer; Torsten Olszak; Martin Wetzke; Florian Beigel; Cornelia Tillack; Johannes Stallhofer; Matthias Friedrich; Christian Steib; Burkhard Göke; Thomas Ochsenkühn; Nazanin Karbalai; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

8.  NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.

Authors:  Neema P Mayor; Bronwen E Shaw; J Alejandro Madrigal; Steven G E Marsh
Journal:  Bone Marrow Res       Date:  2012-10-18

9.  PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites.

Authors:  Jürgen Glas; Julia Seiderer; Darina Czamara; Giulia Pasciuto; Julia Diegelmann; Martin Wetzke; Torsten Olszak; Christiane Wolf; Bertram Müller-Myhsok; Tobias Balschun; Jean-Paul Achkar; M Ilyas Kamboh; Andre Franke; Richard H Duerr; Stephan Brand
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.

Authors:  Jürgen Glas; Julia Seiderer; Martin Wetzke; Astrid Konrad; Helga-Paula Török; Silke Schmechel; Laurian Tonenchi; Christine Grassl; Julia Dambacher; Simone Pfennig; Kerstin Maier; Thomas Griga; Wolfram Klein; Jörg T Epplen; Uwe Schiemann; Christian Folwaczny; Peter Lohse; Burkhard Göke; Thomas Ochsenkühn; Bertram Müller-Myhsok; Matthias Folwaczny; Thomas Mussack; Stephan Brand
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.